Go Pro

Danaher (DHR) Stock Forecast & Price Target

Danaher logo
$211.59 -0.91 (-0.43%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$211.78 +0.19 (+0.09%)
As of 09/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Danaher - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
5
Buy
20

Based on 25 Wall Street analysts who have issued ratings for Danaher in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 25 analysts, 5 have given a hold rating, 18 have given a buy rating, and 2 have given a strong buy rating for DHR.

Consensus Price Target

$228.91
8.19% Upside
According to the 25 analysts' twelve-month price targets for Danaher, the average price target is $228.91. The highest price target for DHR is $270.00, while the lowest price target for DHR is $195.00. The average price target represents a forecasted upside of 8.19% from the current price of $211.59.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for DHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Danaher and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DHR Analyst Ratings Over Time

TypeCurrent Forecast
9/19/25 to 9/19/26
1 Month Ago
8/20/25 to 8/20/26
3 Months Ago
6/21/25 to 6/21/26
1 Year Ago
9/19/24 to 9/19/25
Strong Buy
2 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
18 Buy rating(s)
19 Buy rating(s)
19 Buy rating(s)
17 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$228.91$228.91$233.61$246.35
Forecasted Upside8.19% Upside5.91% Upside31.43% Upside27.44% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

DHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Danaher Stock vs. The Competition

TypeDanaherHealthcare CompaniesBroader Market
Consensus Rating Score
2.88
2.31
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside8.19% Upside754.93% Upside18.43% Upside
News Sentiment Rating
Positive News

See Recent DHR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/16/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 UpgradeHold (C-)Hold (C)
9/9/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Initiated CoverageBuy$250.00+21.81%
7/22/2026 Reiterated RatingBuy$240.00+37.05%
7/22/2026Lower TargetBuy$240.00 ➝ $236.00+34.77%
7/22/2026Boost TargetOutperform$200.00 ➝ $215.00+20.11%
7/22/2026Lower TargetBuy$260.00 ➝ $220.00+25.70%
7/22/2026Lower TargetBuy$235.00 ➝ $200.00+11.73%
7/22/2026Lower TargetEqual Weight$212.00 ➝ $195.00+8.93%
7/6/2026 Reiterated RatingOutperform$230.00+20.30%
6/11/2026Initiated CoverageNeutral$200.00+8.77%
6/3/2026Lower TargetBuy$270.00 ➝ $230.00+30.71%
6/3/2026 Initiated CoverageBuy$210.00+19.34%
6/1/2026DowngradeOutperformPeer Perform
5/26/2026Initiated CoverageBuy$230.00+33.06%
4/24/2026 Lower TargetBuy$265.00 ➝ $230.00+29.72%
4/22/2026Lower TargetOverweight$270.00 ➝ $255.00+38.50%
4/22/2026 Lower TargetOverweight$275.00 ➝ $245.00+25.95%
4/21/2026 Reiterated RatingBuy$245.00+25.80%
4/17/2026Lower TargetOutperform$251.00 ➝ $249.00+28.76%
4/17/2026 Set Target$205.00+6.01%
4/14/2026Lower TargetOverweight$250.00 ➝ $230.00+17.38%
4/13/2026Lower TargetBuy$265.00 ➝ $230.00+18.28%
1/29/2026 Reiterated RatingOverweight
1/16/2026 Boost TargetOutperform$260.00 ➝ $270.00+14.38%
9/22/2025Lower TargetBuy$230.00 ➝ $220.00+15.24%
7/11/2025UpgradeSector PerformSector Outperform$275.00+33.79%
2/3/2025Reiterated RatingOutperformMarket Perform
10/23/2024Reiterated RatingOverweight$315.00 ➝ $315.00+23.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:13 PM ET.


Should I Buy Danaher Stock? DHR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 17, 2026. Please send any questions or comments about these Danaher pros and cons to contact@marketbeat.com.

Danaher
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Danaher Co.:

  • Danaher Co. recently demonstrated strong financial performance by beating analyst expectations in its most recent quarterly report, posting earnings per share of $1.94 against a consensus estimate of $1.85, while also exceeding revenue forecasts with $6.26 billion in sales compared to the expected $6.12 billion.
  • The company maintains a conservative financial position with a debt-to-equity ratio of 0.48 and a current ratio of 1.65, indicating that it has sufficient liquid assets to cover its short-term liabilities and is not overly leveraged, which provides a safety margin for shareholders.
  • Danaher Co. offers a stable income stream with a dividend yield of 0.76% and a low payout ratio of 18.7%, meaning the company retains the majority of its earnings for reinvestment while still providing a consistent cash return to investors that is well-covered by its profits.
  • The stock exhibits lower volatility than the broader market with a beta of 0.78, suggesting that Danaher Co. shares may experience smaller price swings than the overall market, which can be appealing to investors seeking stability in their portfolio.
  • Institutional interest remains strong, as evidenced by recent filings where major entities like National Pension Service increased their stake by 2.8% in the second quarter, and Bank of America Corp DE acquired a new position of over 5 million shares, signaling confidence in the company's long-term outlook.

Danaher
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Danaher Co. for these reasons:

  • The current stock price of $212.45 is trading below the consensus price target of $228.91, but the stock has recently experienced significant volatility, including a gap down event in July where the price dropped from a previous close of $201.11 to $177.57, indicating potential downside risk.
  • Danaher Co. is trading at a premium valuation with a P/E ratio of 37.74, which is significantly higher than the market average, suggesting that investors are paying a high price for each dollar of earnings, which may limit future upside potential if growth slows.
  • Short interest has been increasing recently, with shares shorted rising to 9,639,180 in the latest reporting period, a 9.77% increase from the previous month, indicating that a growing number of traders are betting against the stock's price appreciation.
  • Several institutional investors have reduced their holdings in the second quarter, including NewEdge Advisors LLC which cut its position by 79.7% and Waverly Advisors LLC which trimmed its stake by 31.1%, suggesting that some large investors are losing confidence in the stock's near-term performance.
  • The company's dividend yield of 0.76% is relatively low compared to other income-focused stocks, and while the payout ratio is sustainable, the modest income return may not be sufficient to attract or retain investors seeking higher cash yields from their equity investments.

DHR Forecast - Frequently Asked Questions

According to the research reports of 25 Wall Street equities research analysts, the average twelve-month stock price forecast for Danaher is $228.91, with a high forecast of $270.00 and a low forecast of $195.00.

25 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 5 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DHR shares.

According to analysts, Danaher's stock has a predicted upside of 8.19% based on their 12-month stock forecasts.

Over the previous 90 days, Danaher's stock had 3 upgrades and 1 downgrade by analysts.

Analysts like Danaher more than other "healthcare" companies. The consensus rating for Danaher is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how DHR compares to other companies.


MarketBeat monitors more than a dozen sources for Danaher analyst ratings, with the most recent rating issued on 9/16/2026.
From Our Partners